頸椎病治療市場：依療法、給藥途徑、通路及地區分類

Cervical Spondylosis Treatment Market, By Type of Treatment, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，頸椎病治療市場規模將達到 63.7 億美元，到 2033 年將達到 94.5 億美元。預計 2026 年至 2033 年的複合年成長率為 5.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	63.7億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.80%	2033年市場規模預測：	94.5億美元

頸椎病是一種影響頸部的退化性疾病。它是指頸椎（頸部）因老齡化成長而發生的磨損和損傷，可導致頸部疼痛、僵硬和其他症狀。這種情況有時也被稱為頸椎關節炎或骨關節炎。它涉及頸部軟骨、椎間盤、韌帶和骨骼的自然磨損。這是一種非常常見的疾病，並且會隨著老齡化的成長而加重。在許多情況下，無需特殊治療。如果出現症狀，治療方案包括藥物治療、皮質類固醇注射、物理療法，在某些情況下，還需要手術。

市場動態：

頸椎病負擔日益加重、頸部和背部疼痛盛行率不斷上升、老年人口不斷成長，以及全球對安全有效的頸椎病治療的需求不斷增加，預計這些因素將推動全球頸椎病治療市場的成長。

例如，頸椎病變是老年人脊髓型頸椎病變的一種非常常見的原因，也是老年人最常見的脊椎功能障礙。它非常普遍，並且會隨著老齡化的成長而加重。超過85%的60歲以上族群患有頸椎病。因此，隨著老年人口的成長和頸椎病負擔的加重，人們對安全有效的頸椎病治療方法的需求也日益成長。世界衛生組織（WHO）預測，到2030年，全球六分之一的人口將超過60歲；到2050年，全球60歲以上人口數量預計將加倍，達到21億。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數，介紹了全球頸椎病治療市場主要參與者的概況。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球頸椎病治療市場」報告的目標對象包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業利益相關相關人員。
相關人員可以透過利用分析全球頸椎病治療市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Pfizer Inc.
Abbott Laboratories
AstraZeneca Plc.
Novartis AG
Merck & Co. Inc.
Teva Pharmaceutical Industries Ltd.
Amgen Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Sanofi SA
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Medtronic plc

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI5710

Cervical Spondylosis Treatment Market is estimated to be valued at USD 6.37 Bn in 2026 and is expected to reach USD 9.45 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 6.37 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.80%	2033 Value Projection:	USD 9.45 Bn

Cervical spondylosis is a type of degenerative disease that affects the neck. It is a general term for age-related wear and tear in the cervical spine (neck) that can lead to neck pain, neck stiffness, and other symptoms. Sometimes this condition is called arthritis or osteoarthritis of the neck. It is the natural wearing down of cartilage, disks, ligaments, and bones in the neck. It is very common and worsens with age. In many cases, no specific treatment is required. If symptoms occur, treatments include medication, corticosteroid injections, physiotherapy, and sometimes surgery.

Market Dynamics:

Rise in burden of cervical spondylosis, rising prevalence of neck and back pain, growing geriatric population, and increase in demand for safe & effective cervical spondylosis treatment around the globe is expected to propel the growth of the global cervical spondylosis treatment market.

For instance, cervical spondylosis is a very common cause of myelopathy in the elderly. It is the most common spine dysfunction in elderly people. It is very common and worsens with age. More than 85% of people older than age 60 are affected by cervical spondylosis. Thus, with the growing geriatric population and rise in burden of cervical spondylosis, the demand for safe and effective cervical spondylosis treatment is also increasing. As per the World Health Organization (WHO), by 2030, 1 in 6 people in the world will be aged 60 years or over, and the world's population of people aged 60 years and older will double (2.1 billion) by 2050.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cervical spondylosis treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Medtronic plc, Zimmer Biomet Holdings, Inc., Stryker Corporation, Sanofi S.A., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Merck & Co. Inc., Novartis AG, AstraZeneca Plc., Abbott Laboratories, Pfizer Inc., Bristol-Myers Squibb Company, and Teva Pharmaceutical Industries Ltd., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cervical spondylosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical spondylosis treatment market.

Detailed Segmentation:

By Type of Treatment (Revenue, USD Bn, 2021 - 2033)
Medication
Physical Therapy
Surgery
By End-User (Revenue, USD Bn, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
Homecare Settings
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
Medtronic plc
Zimmer Biomet Holdings, Inc.
Stryker Corporation
Sanofi S.A.
Johnson & Johnson Services, Inc.
GlaxoSmithKline plc
Eli Lilly and Company
Amgen Inc.
Merck & Co. Inc.
Novartis AG
AstraZeneca Plc.
Abbott Laboratories
Pfizer Inc.
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Cervical Spondylosis Treatment Market, By Type of Treatment
- Global Cervical Spondylosis Treatment Market, By Route of Administration
- Global Cervical Spondylosis Treatment Market, By Distribution Channel
- Global Cervical Spondylosis Treatment Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Cervical Spondylosis Treatment Market, By Type of Treatment, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Muscle relaxants
  - Antidepressants
  - Others
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Cervical Spondylosis Treatment Market, By Route of Administration, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Cervical Spondylosis Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Cervical Spondylosis Treatment Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co. Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zimmer Biomet Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies